<?xml version="1.0" encoding="UTF-8"?>
<Bundle xmlns="http://hl7.org/fhir">
  <id value="bundle-paxlovidfctablets"/>
  <meta>
    <versionId value="1"/>
    <lastUpdated value="2024-01-31T00:00:00Z"/>
    <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Bundle-uv-epi"/>
  </meta>
  <language value="zh"/>
  <identifier>
    <system value="https://mcp.fda.gov.tw/"/>
    <value value="paxlovid"/>
  </identifier>
  <type value="document"/>
  <timestamp value="2024-01-31T00:00:00Z"/>
  <entry>
    <fullUrl value="urn:uuid:97739d08-3a4f-4739-9433-2ae56f522dfc"/>
    <resource>
      <Composition>
        <id value="97739d08-3a4f-4739-9433-2ae56f522dfc"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Composition-uv-epi"/>
        </meta>
        <language value="zh"/>
        <contained>				
            <Binary>
                <id value="nirmatrelvir"/>
                <contentType value="image/jpeg"/>
                <data value="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"/>
            </Binary>
        </contained>
        <contained>				
            <Binary>
                <id value="ritonavir"/>
                <contentType value="image/jpeg"/>
                <data value="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"/>
            </Binary>
        </contained>
        <contained>				
            <Binary>
                <id value="category"/>
                <contentType value="image/jpeg"/>
                <data value="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"/>
            </Binary>
        </contained>
        <extension url="http://hl7.org/fhir">
            <valueReference>
                <reference value="#nirmatrelvir"/>
            </valueReference>
        </extension>
        <extension url="http://hl7.org/fhir">
            <valueReference>
                <reference value="#ritonavir"/>
            </valueReference>
        </extension>
        <extension url="http://hl7.org/fhir">
            <valueReference>
                <reference value="#category"/>
            </valueReference>
        </extension>
        <version value="1"/>
				<date value="2024-01-31T00:00:00Z"/>
				<status value="final"/>
        <identifier>
          <system value="https://mcp.fda.gov.tw/"/>
          <value value="97739d08-3a4f-4739-9433-2ae56f522dfc"/>
        </identifier>
        <type>
          <coding>
            <system value="2.16.840.1.113883.6.1"/>
            <code value="34391-3"/>
            <display value="HUMAN PRESCRIPTION DRUG LABEL"/>
          </coding>
        </type>
        <subject>
          <reference value="urn:uuid:cfaeff60-72ff-42e0-bf17-d56db0f2da16"/>
        </subject>
        <author>
          <reference value="urn:uuid:e7fec37a-af43-4b91-9ec3-e7b2c5cb869b"/>
        </author>
        <title value="Paxlovid Human Prescription Drug Label"/>        
      <section>
        <title value=""/>
        <code>
          <coding>
            <system value="2.16.840.1.113883.6.1"/>
            <code value=""/>
            <display value=""/>
          </coding>
        </code>
        <text>
          <status value="generated"/>
          <div xmlns="http://www.w3.org/1999/xhtml">
            <p style="text-align: center">150/100</p>
            <p style="text-align: center">PAXLOVID 150mg/100mg film-coated tablets</p>
            <p style="text-align: right">  028474 </p>
            <p style="text-align: right"></p>
            <p style="text-align: right"> 2024-02-</p>
            <table>
                <tr>
                    <td>
                        <p style="text-align: center">PAXLOVID</p>
                        <p>PAXLOVIDritonavir
                        CYP3A</p>
                        <p> [
                        (4)/ (5.1)</p>
                        <p> (7)]</p>
                        <p> PAXLOVID1) PAXLOVID</p>
                        <p>CYP3A 2)/</p>
                        <p> [ (7)]</p>
                        <p> PAXLOVID</p>
                        <p> [/(5.1)(7)(12)]</p>
                    </td>
                </tr>
            </table>
          </div>
        </text>
        <section>
          <title value="1 "/>
          <code>
            <coding>
              <system value="2.16.840.1.113883.6.1"/>
              <code value=""/>
              <display value=""/>
            </coding>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">
              <p>PAXLOVID  nirmatrelvirritonavirNirmatrelvir SARS-CoV-2  (M<sup>pro</sup>)ritonavir HIV-1 CYP3A</p>
                <p><i>Nirmatrelvir</i></p>
                <p>Nirmatrelvir(1R,2S,5S)-N-((1S)-1-Cyano-2-((3S)-2-oxopyrrolidin-3-yl)ethyl)-3-((2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-</p>
                <p>azabicyclo[3.1.0]hexane-2-carboxamide] C<sub>23</sub>H<sub>32</sub>F<sub>3</sub>N<sub>5</sub>O<sub>4</sub> 499.54</p>
                <p>Nirmatrelvir</p>
                <p><img src="#nirmatrelvir" alt="nirmatrelvir chemical structure"/></p>
                <p><i>Ritonavir</i></p>
                <p>Ritonavir 10-Hydroxy-2-methyl-5-(1-methylethyl)-1- [2-(1 methylethyl)-4-thiazolyl]-3,6-dioxo-8,11-bis(phenylmethyl)-2,4,7,12- tetraazatridecan-13-oic acid, 5-thiazolylmethylester, [5S-(5R*,8R*,10R*,11R*)]Ritonavir C<sub>37</sub>H<sub>48</sub>N<sub>6</sub>O<sub>5</sub>S<sub>2</sub> 720.95</p>
                <p>Ritonavir</p>
                <p><img src="#ritonavir" alt="ritonavir chemical structure"/></p>
            </div>
          </text>
          <section>
            <title value="1.1 "/>
            <code>
              <coding>
                <system value="2.16.840.1.113883.6.1"/>
                <code value=""/>
                <display value=""/>
              </coding>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">                
                <p><i>Nirmatrelvir</i></p>
                <p> 150 mg nirmatrelvir</p>
                <p><i>Ritonavir</i></p>
                <p> 100 mg ritonavir</p>
              </div>
            </text>
          </section> 
          <section>
            <title value="1.2 "/>
            <code>
              <coding>
                <system value="2.16.840.1.113883.6.1"/>
                <code value=""/>
                <display value=""/>
              </coding>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">
                <p><i>Nirmatrelvir</i></p>
                <p>colloidal silicon dioxidecroscarmellose sodiumlactose monohydratemicrocrystalline cellulose sodium stearyl fumaratehydroxy propyl methylcelluloseiron oxide redpolyethylene glycol titanium dioxide</p>
                <p></p>
                <p>150 mg176 mg</p>
                <p><i>Ritonavir</i></p>
                <p> copovidonesorbitan lauratesilica colloidal anhydrouscalcium hydrogen phosphate anhydroussodium stearyl fumaratehypromellosetitanium dioxidemacrogolhydroxypropyl cellulosetalcsilica colloidal anhydrouspolysorbate 80</p>
              </div>
            </text>
          </section> 
          <section>
            <title value="1.3 "/>
            <code>
              <coding>
                <system value="2.16.840.1.113883.6.1"/>
                <code value=""/>
                <display value=""/>
              </coding>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">
                <p>PAXLOVID nirmatrelvirritonavir</p>
                <p>Nirmatrelvir</p>
                <p>Ritonavir</p>
              </div>
            </text>
          </section> 
        <section>
          <title value="1.4 "/>
          <code>
            <coding>
              <system value="2.16.840.1.113883.6.1"/>
              <code value=""/>
              <display value=""/>
            </coding>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">              
              <ul>
                <li><p>Nirmatrelvir</p></li>
              </ul>                
              <p>PFE3CL</p>
              <ul>
                <li><p>Ritonavir</p></li>
              </ul>              
              <p>HR9</p>
            </div>
          </text>
        </section> 
        </section> 
        <section>
          <title value="2 "/>
          <code>
            <coding>
              <system value="2.16.840.1.113883.6.1"/>
              <code value=""/>
              <display value=""/>
            </coding>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">              
              <p> 12 (COVID-19)</p>
              <p></p>
              <ul>
                <li>
                    <p>PAXLOVID COVID-19</p>
                </li>
                <li>
                    <p>PAXLOVID 5 </p>
                </li>
              </ul>
            </div>
          </text>
        </section> 
        <section>
          <title value="3 "/>
          <code>
            <coding>
              <system value="2.16.840.1.113883.6.1"/>
              <code value=""/>
              <display value=""/>
            </coding>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml"/>
          </text>
          <section>
            <title value="3.1 "/>
            <code>
              <coding>
                <system value="2.16.840.1.113883.6.1"/>
                <code value=""/>
                <display value=""/>
              </coding>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">
                <p></p>                
                <p>PAXLOVID 300 mg nirmatrelvir2 150 mg 100 mg ritonavir1 100 mg3 5 COVID 19  5 PAXLOVID 5COVID-19 40</p>
                <p>3 nirmatrelvir  5 SARS-CoV-2</p>               
                <p> COVID-19 PAXLOVID  5</p>
                <p> 8 PAXLOVID 8 </p>
                <p>PAXLOVIDnirmatrelvirritonavir [ (11)]</p>
              </div>
            </text>
          </section> 
        <section>
          <title value="3.3 "/>
          <code>
            <coding>
              <system value="2.16.840.1.113883.6.1"/>
              <code value=""/>
              <display value=""/>
            </coding>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml"/>
          </text>
          <section>
            <title value="3.3.1"/>
            <code>
              <coding>
                <system value="2.16.840.1.113883.6.1"/>
                <code value=""/>
                <display value=""/>
              </coding>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">
                <p>eGFR  60  &lt; 90 mL/min</p>
                <p>eGFR  30  &lt; 60 mL/minPAXLOVID 150 mg nirmatrelvir150 mg 100 mg ritonavir100 mg  5 [ (13)] PAXLOVID</p>
                <p> (eGFR &lt; 30 mL/min)  [ (6.7) (11)]</p>
              </div>
            </text>
        </section>
            <section>
              <title value="3.3.2"/>
              <code>
                <coding>
                  <system value="2.16.840.1.113883.6.1"/>
                  <code value=""/>
                  <display value=""/>
                </coding>
              </code>
              <text>
                <status value="generated"/>
                <div xmlns="http://www.w3.org/1999/xhtml">
                  <p>Child Pugh AChild Pugh B</p>
                  <p>Child-Pugh C nirmatrelvirritonavir  PAXLOVID [(6.6)]</p>                     
                </div>
              </text>
            </section> 
        </section>
        <section>
          <title value="4 "/>
          <code>
            <coding>
              <system value="2.16.840.1.113883.6.1"/>
              <code value=""/>
              <display value=""/>
            </coding>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">
                <p>nirmatrelvirritonavir [  (TEN) Stevens-Johnson]</p>                  
                
                <p>PAXLOVID CYP3A/ nirmatrelvir ritonavir  CYP3A PAXLOVID/ PAXLOVID  CYP3APAXLOVID[ (7.3)]</p>
                <p> CYP3A/ [ (7.3)]</p>
                <p></p>
                <ul>
                    <li><p>1 -alfuzosin</p></li>
                    <li><p>ranolazine</p></li>
                    <li><p>-amiodaronedronedaroneflecainidepropafenonequinidine</p></li>
                    <li><p>colchicine/ [ 1(7.3)]</p></li>
                    <li><p>lurasidonepimozide</p></li>
                    <li><p>silodosin</p></li>
                    <li><p>eplerenoneivabradine</p></li>
                    <li><p>dihydroergotamineergotaminemethylergonovine</p></li>
                    <li><p>HMG-CoAlovastatinsimvastatin PAXLOVID [ 1 (7.3)]</p></li>
                    <li><p>voclosporin</p></li>
                    <li><p>lomitapide</p></li>
                    <li><p>eletriptanubrogepant</p></li>
                    <li><p>finerenone</p></li>
                    <li><p>naloxegol</p></li>
                    <li><p>PDE5sildenafil (Revatio) (pulmonary arterial hypertensionPAH)</p></li>
                    <li><p>/triazolamoral midazolam</p></li>
                    <li><p> 1A/ 2Aflibanserin</p></li>
                    <li><p>tolvaptan</p></li>
                </ul>
                <p> nirmatrelvirritonavir CYP3A CYP3A PAXLOVID [ (7.3)]</p>  
                <ul>
                    <li><p>apalutamide</p></li>
                    <li><p>carbamazepinephenobarbitalprimidonephenytoin</p></li>
                    <li><p>lumacaftor/ivacaftor</p></li>
                    <li><p>rifampinrifapentine</p></li>
                    <li><p>St. Johns Wort (hypericum perforatum)</p></li>
                </ul>
            </div>
          </text>
        </section>              
          </section> 
        </section> 
        <section>
            <section>
                <title value="5 "/>
                <code>
                  <coding>
                    <system value="2.16.840.1.113883.6.1"/>
                    <code value=""/>
                    <display value=""/>
                  </coding>
                </code>
                <text>
                  <status value="generated"/>
                  <div xmlns="http://www.w3.org/1999/xhtml"/>
                </text>
                <section>
          <title value="5.1 /"/>
          <code>
            <coding>
              <system value="2.16.840.1.113883.6.1"/>
              <code value=""/>
              <display value=""/>
            </coding>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml"/>
          </text>
          <section>
            <title value="5.1.1"/>
            <code>
              <coding>
                <system value="2.16.840.1.113883.6.1"/>
                <code value=""/>
                <display value=""/>
              </coding>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">
                <p> CYP3A PAXLOVID ritonavir CYP3A   PAXLOVID CYP3A CYP3A</p>
                <p> CYP3A PAXLOVID</p>
                <p></p>
                <ul>
                    <li><p> </p></li>
                    <li><p>PAXLOVID</p></li>
                </ul>
                
                
                <p> PAXLOVID / [tacrolimuscyclosporine ()]</p>
                <p> PAXLOVID /[ (4)  (7)] 11 PAXLOVID</p>
                <p> PAXLOVID [ (7) (12)]</p>
              </div>
            </text>
        </section>
            <section>
              <title value="5.1.2"/>
              <code>
                <coding>
                  <system value="2.16.840.1.113883.6.1"/>
                  <code value=""/>
                  <display value=""/>
                </coding>
              </code>
              <text>
                <status value="generated"/>
                <div xmlns="http://www.w3.org/1999/xhtml">
                  <p> PAXLOVID  [TEN] Stevens-Johnson  [/(8.1)]  PAXLOVID/</p>
                </div>
              </text>
            </section>
              <section>
                <title value="5.1.3"/>
                <code>
                  <coding>
                    <system value="2.16.840.1.113883.6.1"/>
                    <code value=""/>
                    <display value=""/>
                  </coding>
                </code>
                <text>
                  <status value="generated"/>
                  <div xmlns="http://www.w3.org/1999/xhtml">
                    <p> ritonavir  PAXLOVID</p>
                  </div>
                </text>
                <section>
                  <title value="5.1.4 1 (HIV-1)"/>
                  <code>
                    <coding>
                      <system value="2.16.840.1.113883.6.1"/>
                      <code value=""/>
                      <display value=""/>
                    </coding>
                  </code>
                  <text>
                    <status value="generated"/>
                    <div xmlns="http://www.w3.org/1999/xhtml">
                      <p> nirmatrelvirritonavir HIV-1 HIV [ (4) (7)]</p>
                    </div>
                  </text>
                </section> 
              </section> 
            </section> 
          </section>         
        <section>
          <title value="6 "/>
          <code>
            <coding>
              <system value="2.16.840.1.113883.6.1"/>
              <code value=""/>
              <display value=""/>
            </coding>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml"/>
          </text>
          <section>
            <title value="6.1 "/>
            <code>
              <coding>
                <system value="2.16.840.1.113883.6.1"/>
                <code value=""/>
                <display value=""/>
              </coding>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">
                <p><i></i></p>
                <p> nirmatrelvir ritonavir ritonavirCOVID-19</p>
                <p> nirmatrelvir-nirmatrelvir (AUC)PAXLOVID 11 nirmatrelvir (AUC) PAXLOVID  3 3</p>
                <p>ritonavir-ritonavir (AUC) PAXLOVID 5()8() </p>
                <p>   2 - 4% 15 - 20%</p>
                <p><i></i></p>
                <p>//</p>
                <p> COVID-19 </p>
                <p><i></i></p>
                <p></p>
                <p><i>Ritonavir</i></p>
                <p>ritonavir3,500  3,500  (MACDP)ritonavir 2.7%</p>
                <p>ritonavir 2.4% [95% (CI)1.9%2.9%]ritonavir  2.9%95% CI2.4%3.5%ritonavir ritonavir</p>
                <p></p>
                <p><i>Nirmatrelvir</i></p>
                <p> 1000 mg/kg/ nirmatrelvir [ 6 - 17 7 - 19]--  1000 mg/kg/nirmatrelvir  (AUC 24 )PAXLOVID  9-  1000 mg/kg/ 9%  1000 mg/kg/(AUC 24 ) PAXLOVID  11 1000 mg/kg/ - 300 mg/kg/ (AUC 24 ) PAXLOVID 3  6 20 (LD) 1000 mg/kg/ nirmatrelvir (PPND)  nirmatrelvir  (PND) 17 8% PND 21 7%28  56 mg/kg/ (AUC 24)PAXLOVID 9  300 mg/kg/(AUC 24 ) PAXLOVID 6</p>
                <p><i>Ritonavir</i></p>
                <p>6 - 1701535 75 mg/kg/  6 - 1902550 110 mg/kg/ritonavir (AUC)  PAXLOVID 5()8() ritonavir (AUC) PAXLOVID 10  (AUC)PAXLOVID8 (pre and postnatal developmentPPND) 6 20 01535 60 mg/kg/ritonavir (AUC)PAXLOVID10</p>
              </div>
            </text>
          </section> 
        <section>
          <title value="6.2 "/>
          <code>
            <coding>
              <system value="2.16.840.1.113883.6.1"/>
              <code value=""/>
              <display value=""/>
            </coding>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">
              <p><i></i></p>
              <p> nirmatrelvir  nirmatrelvir ritonavir ritonavir  PAXLOVID PAXLOVID  COVID19  COVID19</p>
              <p><i></i></p>
              <p> PPND nirmatrelvir (AUC 24) PAXLOVID  9 8%  (AUC 24 ) PAXLOVID 6</p>
            </div>
          </text>
        </section> 
        <section>
          <title value="6.3 "/>
          <code>
            <coding>
              <system value="2.16.840.1.113883.6.1"/>
              <code value=""/>
              <display value=""/>
            </coding>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">
              <p></p>              
              <p>Ritonavir  [ (7.3)]</p>
            </div>
          </text>
        </section> 
        <section>
          <title value="6.4 "/>
          <code>
            <coding>
              <system value="2.16.840.1.113883.6.1"/>
              <code value=""/>
              <display value=""/>
            </coding>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">
              <p>PAXLOVID 12 &lt; 40 kgPAXLOVID   12  40 kg nirmatrelvirritonavir(  EPIC-HR) [/ (8.2) (11) (12.1)]</p>
            </div>
          </text>
        </section> 
        <section>
          <title value="6.5 "/>
          <code>
            <coding>
              <system value="2.16.840.1.113883.6.1"/>
              <code value=""/>
              <display value=""/>
            </coding>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">
              <p>PAXLOVID   65  [ / (8.2)(12.1)] EPIC-HR EPIC-SR  PAXLOVID (N = 1,578)165( 10%) 65 39(2%) 75 </p>
            </div>
          </text>
        </section> 
        <section>
          <title value="6.6 "/>
          <code>
            <coding>
              <system value="2.16.840.1.113883.6.1"/>
              <code value=""/>
              <display value=""/>
            </coding>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">
              <p>Child Pugh AChild Pugh B PAXLOVIDChild-Pugh C nirmatrelvir ritonavirChild-Pugh C  PAXLOVID [/ (5.1.3)(11)]</p>
            </div>
          </text>
        </section> 
        <section>
          <title value="6.7 "/>
          <code>
            <coding>
              <system value="2.16.840.1.113883.6.1"/>
              <code value=""/>
              <display value=""/>
            </coding>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">
              <p>
                nirmatrelvirPAXLOVID</p>
                <p>eGFR  60  &lt; 90 mL/mineGFR  30  &lt; 60 mL/min PAXLOVID (eGFR &lt;30 mL/min) (eGFR &lt;15 mL/min) PAXLOVID [(3.3.1) (11)] PAXLOVID/ </p>                
            </div>
          </text>
        </section> 
    </section>
        <section>
          <title value="7 "/>
          <code>
            <coding>
              <system value="2.16.840.1.113883.6.1"/>
              <code value=""/>
              <display value=""/>
            </coding>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml"/>
          </text>
          <section>
            <title value="7.1(PAXLOVID)"/>
            <code>
              <coding>
                <system value="2.16.840.1.113883.6.1"/>
                <code value=""/>
                <display value=""/>
              </coding>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">                
                <p>PAXLOVIDnirmatrelvirritonavir CYP3ACYP2D6P-gp  OATP1B1PAXLOVID CYP3ACYP2D6P-gp  OATP1B1 PAXLOVID CYP3A/ [ (4) (7.3) 1] CYP3A1</p>
              </div>
            </text>
          </section> 
          <section>
            <title value="7.2(PAXLOVID)"/>
            <code>
              <coding>
                <system value="2.16.840.1.113883.6.1"/>
                <code value=""/>
                <display value=""/>
              </coding>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">
                <p>Nirmatrelvirritonavir CYP3A CYP3A nirmatrelvir ritonavir PAXLOVID [ (4)  (7.3) 1]</p>
              </div>
            </text>
          </section> 
          <section>
            <title value="7.3"/>
            <code>
              <coding>
                <system value="2.16.840.1.113883.6.1"/>
                <code value=""/>
                <display value=""/>
              </coding>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">
                <p> 1 [ (4)/ (5.1)] 1 PAXLOVID  CYP3A( ritonavir</p>
              </div>
            </text>
          </section>           
        </section> 
        <section>
          <title value="8 /"/>
          <code>
            <coding>
              <system value="2.16.840.1.113883.6.1"/>
              <code value=""/>
              <display value=""/>
            </coding>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml"/>
          </text>
          <section>
            <title value="8.1 /"/>
            <code>
              <coding>
                <system value="2.16.840.1.113883.6.1"/>
                <code value=""/>
                <display value=""/>
              </coding>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">
                <p></p>    
                <ul>
                    <li><p> [ (5.1.2)]</p></li>
                </ul>            
                
              </div>
            </text>
          </section> 
          <section>
            <title value="8.2 "/>
            <code>
              <coding>
                <system value="2.16.840.1.113883.6.1"/>
                <code value=""/>
                <display value=""/>
              </coding>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">
                <p>  PAXLOVID 18SARS-CoV-2 2/3  5 12 PAXLOVIDnirmatrelvir/ritonavir 300 mg/100 mg 5 COVID-19 [ (12) ]</p>
                <ul>
                    <li><p>C4671005 (EPIC-HR)</p></li>
                    <li><p>C4671002 (EPIC-SR)</p></li>
                </ul>
                <p>1</p>
                <p> 28 C4671005 (EPIC-HR)1,038PAXLOVID1,053PAXLOVID   1%  5% &lt;1%3% 2%</p>
                <p> C4671002 (EPIC-SR) 1540 PAXLOVID528 EPIC HR</p>
              </div>
            </text>
          </section> 
          <section>
            <title value="8.3 "/>
            <code>
              <coding>
                <system value="2.16.840.1.113883.6.1"/>
                <code value=""/>
                <display value=""/>
              </coding>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">
                <p><i>COVID-19 </i></p>
                <p>PAXLOVID </p>
                <p> [/(5.1.2)]</p>
                <p>Stevens-Johnson[(5.1.2)]</p>
                <p></p>
                <p></p>
                <p></p>
                <p></p>
              </div>
            </text>
          </section> 
        </section> 
        <section>
          <title value="9 "/>
          <code>
            <coding>
              <system value="2.16.840.1.113883.6.1"/>
              <code value=""/>
              <display value=""/>
            </coding>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">
              <p>PAXLOVID PAXLOVID</p>
            </div>
          </text>
        </section> 
        <section>
          <title value="10 "/>
          <code>
            <coding>
              <system value="2.16.840.1.113883.6.1"/>
              <code value=""/>
              <display value=""/>
            </coding>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml"/>
          </text>
          <section>
            <title value="10.1 "/>
            <code>
              <coding>
                <system value="2.16.840.1.113883.6.1"/>
                <code value=""/>
                <display value=""/>
              </coding>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">                
                <p>Nirmatrelvir 2  (SARS-CoV-2) [  (11.1)]</p>
                <p>Ritonavir HIV-1 SARS-CoV-2 M<sup>pro</sup>Ritonavir CYP3Anirmatrelvir nirmatrelvir</p>
              </div>
            </text>
          </section> 
          <section>
            <title value="10.2 "/>
            <code>
              <coding>
                <system value="2.16.840.1.113883.6.1"/>
                <code value=""/>
                <display value=""/>
              </coding>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">
                <p><i></i></p>
                <p>(Cmax) 3nirmatrelvir QTc </p>              
              </div>
            </text>
          </section> 
          <section>
            <title value="10.3 "/>
            <code>
              <coding>
                <system value="2.16.840.1.113883.6.1"/>
                <code value=""/>
                <display value=""/>
              </coding>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml"/>
            </text>
            <section>
              <title value="10.3.1"/>
              <code>
                <coding>
                  <system value="2.16.840.1.113883.6.1"/>
                  <code value=""/>
                  <display value=""/>
                </coding>
              </code>
              <text>
                <status value="generated"/>
                <div xmlns="http://www.w3.org/1999/xhtml">
<p><i>Nirmatrelvir</i></p>
<p> nirmatrelvir</p>
<p> S. typhimuriumE. coli Ames TK6nirmatrelvir </p>
<p> 14 60200 1000 mg/kg/ nirmatrelvir6 32 1000 mg/kg/ AUC 24  PAXLOVID 5</p>
<p><i>Ritonavir</i></p>
<p>ritonavir 50100  200 mg/kg/ AUC  PAXLOVID 25 AUC 24  PAXLOVID 25 715  30 mg/kg/  PAXLOVID  5</p>
<p>S. typhimuriumE. coliAmesritonavir </p>
<p>Ritonavir PAXLOVID1827  </p>
                </div>
              </text>
            </section> 
            <section>
              <title value="11 "/>
              <code>
                <coding>
                  <system value="2.16.840.1.113883.6.1"/>
                  <code value=""/>
                  <display value=""/>
                </coding>
              </code>
              <text>
                <status value="generated"/>
                <div xmlns="http://www.w3.org/1999/xhtml">                  
                  <p>Nirmatrelvir/ritonavir COVID-19</p>
                  <p> 100 mg ritonavir 250 mg 750 mg 0.83 2.5  75 mg 500 mg 0.25 1.67nirmatrelvir AUC nirmatrelvir 2 2</p>
                  <p>Nirmatrelvir/ritonavir 2</p>
                  <p> 2 Nirmatrelvir ritonavir</p>
                  <!-- Table placeholder-->
                  
                  <p>CL/F =hr =L/hr = T1/2 =Tmax=</p>
                  <p> CmaxVz/F =</p>
                  <p>a.  300 mg nirmatrelvir2  150 mg 100 mg ritonavir</p>
                  <p></p>
                  <p>b.  nirmatrelvir 300 mg-12</p>
                  <p>0 12ritonavir 100 mg</p>
                  <p>c. 300 mg nirmatrelvir 100 mg ritonavir 3</p>
                  <p>d. </p>
                  <p>e.  0 300 mg nirmatrelvir-12012 24</p>
                  <p> 100 mg ritonavir^19 F-NMR</p>
                  <p>f.  600 mg^14 C-ritonavir^14 Critonavir6</p>
                  <p></p>                  
                  <p>EPIC-HR PAXLOVID COVID-19 5 nirmatrelvir</p>
                  <p> 3</p>                  
                  <p> 3 300 mg/100 mg Nirmatrelvir/Ritonavir COVID-19 5 Nirmatrelvir</p>
                  <!-- Table placeholder-->
                  
                  <p>Cmax=Cmin = (Ctrough)</p>
                  <p>a.  10 90</p>
                  <p>b. 1,106 PK</p>
                  <p>c. AUCtau = 0 12-</p>
                  <p></p>
                  <p>(800-100050%)nirmatrelvir </p>
                  <p><i></i></p>
                  <p>18 86/nirmatrelvir</p>
                  <p></p>
                  <p> 12 40 kg  nirmatrelvir</p>
                  <p><i></i></p>
                  <p>nirmatrelvir 100 mg0.33ritonavir 100 mgnirmatrelvir4  nirmatrelvir Cmax AUC 30% 24% 38% 87% 48% 204%</p>
                  <p> 4 Nirmatrelvir/Ritonavir</p>
                  <!-- Table placeholder-->
                                    
                  <p>AUCinf =-Cmax =CV=SD =T1/2=Tmax = Cmax  Tmax T1/2  SD  %CV</p>
                  <p></p>
                  <p>Child-Pugh B nirmatrelvir 100 mg 0.33100 mg ritonavirnirmatrelvir  Child-Pugh C nirmatrelvir 
                  ritonavir</p>
                  <p><i></i></p>
                  <p> 5nirmatrelvir Cmax AUC</p>
                  
                  <p> 5Nirmatrelvir</p>
                  <!-- Table placeholder-->
                                    
                  <p>AUC=-AUCinf=-</p>
                  <p>AUCtau = tau()-CI =</p>
                  <p>Cmax =</p>
                  <p>a. CarbamazepineAUC = AUCinfItraconazoleAUC = AUCtau</p>
                  <p>b.  8 15Carbamazepine 300 mg 1 - 3 100 m</p>
                  <p>g 4 - 7 200 mg</p>                  
                  <p> 6nirmatrelvir/ritonavir  Cmax AUC</p>
                  
                  <p> 6Nirmatrelvir/Ritonavir</p>
                  <!-- Table placeholder-->
                  
                  <p>AUC =-CI =Cmax =Pgp = p</p>
                  <p>a. midazolamdabigatranAUC=AUCinf</p>
                  <p>b. midazolam= nirmatrelvir/ritonavir midazolam = Midazolam</p>                 
                  
                  <p>MidazolamCYP3Adabigatran = nirmatrelvir/ritonavirdabigat ran = DabigatranDabigatranP-gp</p>
                </div>
              </text>
              <section>
                <section>
                    <title value="11 "/>
                    <code>
                      <coding>
                        <system value="2.16.840.1.113883.6.1"/>
                        <code value=""/>
                        <display value=""/>
                      </coding>
                    </code>
                    <text>
                      <status value="generated"/>
                      <div xmlns="http://www.w3.org/1999/xhtml">
                        <p> P450 (CYP)</p>
                        <ul>
                            <li><p>NirmatrelvirCYP3ACYP1A2CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6Nirmatrelvir  CYP2B62C82C93A4  CYP</p></li>
                            <li><p>RitonavirCYP2D6 CYP3ARitonavir CYP1A2CYP2C9CYP2C19CYP2B6CYP3A</p></li>
                        </ul>
                        <p>NirmatrelvirP-gp OATP1B1NirmatrelvirP-gpBCRPMATE1MATE2KNTCPOAT1OAT2OAT3OCT1OCT2PEPT1OATP1B1OATP1B3OATP2B1OATP4C1</p>
                    </div>
                    </text>
                    <section>
                <title value="11.1 "/>
                <code>
                  <coding>
                    <system value="2.16.840.1.113883.6.1"/>
                    <code value=""/>
                    <display value=""/>
                  </coding>
                </code>
                <text>
                  <status value="generated"/>
                  <div xmlns="http://www.w3.org/1999/xhtml">
                    <p><i></i></p>                    
                    <p>Nirmatelvir  SARS-CoV-2 (M<sup>pro</sup>) 
                    3C-like (3CLpro) 5 (nsp5)SARS-CoV-2 M<sup>pro</sup>  pp1a
                    pp1abnimatrelvir SARS-CoV-2 M<sup>pro</sup>Ki 3.1 nMIC 50  19.2 nMX nirmatrelvir SARS-CoV-2 M<sup>pro</sup></p>                    
                    
                    <p><i></i></p>
                    <p></p>
                    
                    <p>Nirmatrelvir SARS-CoV-2USA-WA1/2020 (dNHBE) 3EC<sub>50</sub> EC 90 62 nM (31ng/mL) 181 nM (90 ng/mL)</p>                    
                    
                    <p>Nirmatrelvir Omicron BA.2BA.2.12.1BA.4BA.4.6BA.5BF.7BQ.1BQ.1.11  XBB.1.5 P-gp Vero E6-TMPRSS2 Nirmatrevir  OmicronEC<sub>50</sub> 83
                    nM39-146 nM USA-WA1/2020 EC<sub>50</sub> 1.5</p>                    
                    
                    <p> Vero E6 P-gpnirmatrelvir SARS-CoV-2 AlphaBetaGammaDeltaLambdaMu Omicron
                    BA.1Nirmatrevir   EC<sub>50</sub> 25 nM16-141 nMBeta   USA WA1/2020EC<sub>50</sub> 3.7 USA-WA1/2020 EC 50 1.1</p>
                    
                    <p></p>
                    <p> SARS-CoV-2 Delta EPIC-HRPAXLOVID  5 RNA 0.83 log 10copies/mLmITT1 COVID-19 (mAb) 5  mITT25  SARS-CoV-2 Delta (79%) Omicron (19%) EPIC-SR PAXLOVID 5 RNA</p>
                    <p> 1.05 log 10 copies/mL Delta Omicron PAXLOVID 5 RNA EPIC-HR EPIC-SR</p>

                    <p><i></i></p>
                    <p></p>
                    <p> nirmatrelvirSARS-CoV-2 M<sup>pro</sup> SARS-CoV-2 M<sup>pro</sup> SARS-CoV-2  SARS-CoV-2 M<sup>pro</sup> 7nirmatrelvir SARS-CoV-2  M<sup>pro</sup> M<sup>pro</sup>
                    M<sup>pro</sup>  M<sup>pro</sup>M<sup>pro</sup> S301P T304I M<sup>pro</sup> C nsp5/nsp6 P6 P3 M<sup>pro</sup> nirmatrelvir</p>

                    <p> 7NirmatrelvirSARS-CoV-2</p>
                    <!-- Table placeholder-->
                    
                    <p>ND =</p>
                    <p> SARS-CoV-2 M<sup>pro</sup> SARS-CoV-2 M<sup>pro</sup></p>
                    <p>nirmatrelvir 3 Ki Y54A (25)F140A (21)F140L (7.6)F140S (260)G143S (3.6)S144A (46)S144E (480)S144T (170)H164N (6.7)E166A (35)E166G (6.2)E166V (7,700)H172Y (250)A173S (4.1)A173V (16)R188G (38)Q192L (29)Q192P (7.8)V297A (3.0)M<sup>pro</sup> nirmatrelvir 3 T21I+S144A (20)T21I+E166V (11,000)T21I+A173V (15)L50F+E166V (4,500)T135I+T304I (5.1)F140L+A173V
                    (95)H172Y+P252L (180)A173V+T304I (28)T21I+S144A+T304I (51)T21I+A173V+T304I (55)L50F+E166A+L167F (210)T21I+L50F+A193P+S301P (7.3)L50F+F140L+L167F+T304I(190)T21I+C160F+A173V+V186A+T304I
                    (28)nirmatrelvir &lt;3T21I (1.6)L50F
                    (0.2)P108S (2.9)T135I (2.2)C160F (0.6)L167F (0.9)T169I (1.4)V186A (0.8)A191V (0.8)A193P (0.9)P252L (0.9)S301P (0.2)T304I (1.0)T21I+T304I (1.8)L50F+T304I (1.3) </p>

                    <p></p>
                    <p> EPIC-HR/SR n=907PAXLOVIDn=946 SARSCoV2 M<sup>pro</sup> 3 PAXLOVID  PAXLOVID2.5  PAXLOVID PAXLOVID M<sup>pro</sup>T98I/R/del(n=4)E166V(n=3) W207L/R/del(n=4) M<sup>pro</sup> PAXLOVIDA5328S/V(n=7)  S6799A/P/Y (n=4)  M<sup>pro</sup></p>
                    
                    <p>M<sup>pro</sup> M<sup>pro</sup> PAXLOVID </p>
                    
                    <p><i> RNA COVID-19</i></p>
                    <p>EPIC-HR EPIC-SR COVID-19 PAXLOVID RNA
                    COVID-19</p>
                    <p>EPIC-HREPIC-SRPAXLOVID10 /14SARS-CoV-2
                    RNACOVID-19 RNAPAXLOVID</p>
                    <p>RNA (&lt;LLOQ)PAXLOVID</p>

                    <p>EPIC-HR 59 PAXLOVID RNA  2 (3%) M<sup>pro</sup> nirmatrelvir 1 E166V 1 T304I 14 RNA &lt; LLOQ</p>

                    <p>RNACOVID-19 PAXLOVID5 28PAXLOVIDRNA  </p>

                    <p> RNA 28 PAXLOVID</p>
                    
                    <p> 14 SARSCoV2 RNA  RNA</p>                    
                    
                    <p><i></i></p>                                        
                    <p>Nirmatrelvirremdesivir SARS-CoV-2M<sup>pro</sup> </p>                    
                  </div>
                </text>
              </section> 
            </section> 
            <section>
              <title value="12 "/>
              <code>
                <coding>
                  <system value="2.16.840.1.113883.6.1"/>
                  <code value=""/>
                  <display value=""/>
                </coding>
              </code>
              <text>
                <status value="generated"/>
                <div xmlns="http://www.w3.org/1999/xhtml"/>
              </text>
              <section>
                <title value="12.1  COVID-19 
                (EPIC-HR)"/>
                <code>
                  <coding>
                    <system value="2.16.840.1.113883.6.1"/>
                    <code value=""/>
                    <display value=""/>
                  </coding>
                </code>
                <text>
                  <status value="generated"/>
                  <div xmlns="http://www.w3.org/1999/xhtml">                    
                    <p>EPIC-HR (NCT04960202) SARS-CoV-2  2/318   1 BMI &gt;25   60 COVID-19 5</p>
                    <p> 1:1 PAXLOVID nirmatrelvir/Ritonavir 300 mg/100 mg</p>
                    <p> 12 5 COVID-19 COVID-19PAXLOVID  28COVID-19 (mITT) COVID-19 3mITT1  COVID-19 [mAb] 5</p>
                    <p> mITT2 5</p>                    
                    
                    <p>2,113 PAXLOVID  4551%71%15%9% 4%1%41% 67%3(  3)49%RNA () 4.71 log 10 copies/mL (2.89)27% RNA  10^ 7log 10copies/mL6%  COVID-19 mITT mITT1</p>
                                        
                    <p>PAXLOVID</p>
                                        
                    <p> PAXLOVID 2.0%
                    4.2%</p>                    
                    
                    <p> 8 mITT1PAXLOVID  mITT1 86% (95% CI: 72%, 93%)</p>
                    
                    <p> 828COVID-19COVID-19</p>
                    <!-- Table Placeholder-->
                    
                    <p>CI =COVID-19 = 2019mAb =mITT1 = 1 COVID-19 mAb 5 </p>
                    <p>PAXLOVID754mITT  -6.5%95% CI (-9.3%, -3.7%) p &lt; 0.0001</p>
                    <p>a.  Kaplan-Meier 28 28(censored)</p>
                    
                    <p>b.  24PAXLOVID  0 15 (1%)</p>                    
                    
                    <p>mITT mITT2</p>
                    <p> 1</p>

                    <p><b> 1 28COVID-19 5 COVID19 </b> EPIC-HR</p>
                    <p><img src="#category" alt="Subpopulation analysis"/></p>                    
                    <p>BMI =COVID-19 = 2019mAb =mITT =SARS-CoV-2 = 2</p>
                    <p>N = mITT1COVID-19  mITT2</p>
                    <p> Elecsys  SARS-CoV-2 S Elecsys SARS-CoV-2(N) </p>
                    <p> 2 95%</p>                   
                    
                    <p> SARS-CoV-2490PAXLOVID1 (0.2%)4798(1.7%) 28 COVID-19  [ -1.47% (-2.70%, -0.25%)]</p>
                  </div>
                </text>
              </section> 
              <section>
                <title value="12.2  COVID-19 "/>
                <code>
                  <coding>
                    <system value="2.16.840.1.113883.6.1"/>
                    <code value=""/>
                    <display value=""/>
                  </coding>
                </code>
                <text>
                  <status value="generated"/>
                  <div xmlns="http://www.w3.org/1999/xhtml">
                    <p>COVID-19  COVID-19  (EPIC-SR)</p>
                      <p>PAXLOVID COVID-19 COVID-19</p>
                      
                      
                      <p>EPIC-SR (NCT05011513) SARS-CoV-2  2/3 18  COVID-19 5   COVID-19 1
                      EPIC-HR202112 19 1,075 (1:1) PAXLOVID  12 559%</p>
                      
                      
                      <p>28PAXLOVID  COVID-19 </p>
                      
                      
                      <p> 1 28COVID-19  </p>                      
                  </div>
                </text>
              </section> 
            </section> 
            <section>
              <title value="13 "/>
              <code>
                <coding>
                  <system value="2.16.840.1.113883.6.1"/>
                  <code value=""/>
                  <display value=""/>
                </coding>
              </code>
              <text>
                <status value="generated"/>
                <div xmlns="http://www.w3.org/1999/xhtml"/>
              </text>
            </section> 
            <section>
              <title value="13.1 "/>
              <code>
                <coding>
                  <system value="2.16.840.1.113883.6.1"/>
                  <code value=""/>
                  <display value=""/>
                </coding>
              </code>
              <text>
                <status value="generated"/>
                <div xmlns="http://www.w3.org/1999/xhtml">
                  <p><i></i></p>
                  <p>PAXLOVID nirmatrelvirritonavir</p>
                  <ul>
                    <li><p>Nirmatrelvir 150 mgPFE 3CL</p></li>
                    <li><p>Ritonavir 100 mgH R9</p></li>
                  </ul>
                  
                  <p>Nirmatrelvirritonavir</p>
                  
                  <p> 30  5 </p>
                  
                  <p> 4  nirmatrelvir 150 mg 2ritonavir 100 mg </p>
                </div>
              </text>
              <section>
                <title value="13.2 "/>
                <code>
                  <coding>
                    <system value="2.16.840.1.113883.6.1"/>
                    <code value=""/>
                    <display value=""/>
                  </coding>
                </code>
                <text>
                  <status value="generated"/>
                  <div xmlns="http://www.w3.org/1999/xhtml">
                    <p></p>
                  </div>
                </text>
                <section>
                  <title value="13.3 "/>
                  <code>
                    <coding>
                      <system value="2.16.840.1.113883.6.1"/>
                      <code value=""/>
                      <display value=""/>
                    </coding>
                  </code>
                  <text>
                    <status value="generated"/>
                    <div xmlns="http://www.w3.org/1999/xhtml">
                      <p></p>
                      <p> 25C</p>                      
                    </div>
                  </text>
                </section> 
            </section> 
          </section>
        </section> 
        </section>
        <section>
          <title value="PATIENT MEDICATION INFORMATION "/>
          <code>
            <coding>
              <system value="2.16.840.1.113883.6.1"/>
              <code value="68498-5"/>
              <display value="PATIENT MEDICATION INFORMATION"/>
            </coding>
          </code>
          <text>
            <status value="generated"/>
            <div xmlns="http://www.w3.org/1999/xhtml">
              <p style="text-align:center"></p>
              <p style="text-align:center">150/100</p>
              <p style="text-align:center">(nirmatrelvir tablets; ritonavir tablets)</p>
              <p style="text-align:center"></p>

                <table>
                  <tr>
                    <td colspan="3">
                      <p> PAXLOVID </p>
                      <p>PAXLOVID  PAXLOVID  </p>
                      <p>PAXLOVID</p>
                      <p>	 </p>
                    </td>
                  </tr>
                    <tr>
                        <td>o alfuzosin</td>
                        <td>o amiodarone</td>
                        <td>o apalutamide</td>
                    </tr>
                    <tr>
                        <td>o carbamazepine</td>
                        <td>o colchicine</td>
                        <td>o dihydroergotamine</td>
                    </tr>
                    <tr>
                        <td>o dronedarone</td>
                        <td>o eletriptan</td>
                        <td>o eplerenone</td>
                    </tr>
                    <tr>
                        <td>o ergotamine</td>
                        <td>o finerenone</td>
                        <td>o flecainide</td>
                    </tr>
                    <tr>
                        <td>o flibanserin</td>
                        <td>o ivabradine</td>
                        <td>o lomitapide</td>
                    </tr>
                    <tr>
                        <td>o lovastatin</td>
                        <td>o lumacaftor/ivacaftor</td>
                        <td>o lurasidone</td>
                    </tr>
                    <tr>
                        <td>o methylergonovine</td>
                        <td>o midazolam (oral)</td>
                        <td>o naloxegol</td>
                    </tr>
                    <tr>
                        <td>o phenobarbital</td>
                        <td>o phenytoin</td>
                        <td>o pimozide</td>
                    </tr>
                    <tr>
                        <td>o primidone</td>
                        <td>o propafenone</td>
                        <td>o quinidine</td>
                    </tr>
                    <tr>
                        <td>o ranolazine</td>
                        <td>o rifampin</td>
                        <td>o rifapentine</td>
                    </tr>
                    <tr>
                        <td>o St. Johns Wort (hypericum perforatum)</td>
                        <td>o sildenafil (Revatio) for pulmonary arterial hypertension</td>
                        <td>o silodosin</td>
                    </tr>
                    <tr>
                        <td>o simvastatin</td>
                        <td>o tolvaptan</td>
                        <td>o triazolam</td>
                    </tr>
                    <tr>
                        <td>o ubrogepant</td>
                        <td>o voclosporin</td>
                        <td></td>
                    </tr>
                </table>
            <p> PAXLOVID PAXLOVID  PAXLOVID </p>
            <p>	 nirmatrelvirritonavir PAXLOVID PAXLOVID PAXLOVID </p>
            <p>PAXLOVID</p>
            <p>PAXLOVID 12(COVID-19) </p>
            <p>PAXLOVID COVID-19 </p>
            <p>PAXLOVID</p>
            <ul>
              <li>PAXLOVID</li>
              <li></li>
              <li> 1 (HIV-1)PAXLOVID  HIV-1 </li>
              <li> PAXLOVID </li>
              <li> PAXLOVID  PAXLOVID </li>
            </ul>
            <p></p>
            <ul>
              <li> PAXLOVID </li>
              <li>PAXLOVID</li>
              <li></li>
            </ul> 
            <p>PAXLOVID  PAXLOVID </p>
            <p>PAXLOVID</p>
            <ul>
              <li> PAXLOVID</li>
              <li>PAXLOVID  2 nirmatrelvir  ritonavir  5 
                <ul>
                  <li>Nirmatrelvir</li>
                  <li>Ritonavir</li>
                </ul>
              </li>
              <li> </li>
              <li>PAXLOVID
                <ul>
                  <li>PAXLOVID</li>
                  <li> 3 </li>
                </ul>
              </li>
              <li></li>
              <li> PAXLOVID</li>
              <li>PAXLOVID</li>
              <li> 8  PAXLOVID 8  2  PAXLOVID</li>
              <li> PAXLOVID</li>
              <li> ritonavir  cobicistat  C  HIV-1 </li>
             </ul>
             <p> 5 </p>
             <p>PAXLOVID </p>
             <p>PAXLOVID :</p>
             <p>	 PAXLOVID  PAXLOVID </p>
             <table border="0">
              <tr>
              </tr>
              <tr>
                  <td>o	</td>
                  <td>o	</td>
              </tr>
              <tr>
                  <td>o	</td>
                  <td>o	</td>
              </tr>
              <tr>
                  <td>o	</td>
                  <td>o	</td>
              </tr>
          </table>
          <p>	PAXLOVID</p>
          <table border="0">
            <tr>
            </tr>
            <tr>
                <td>o	</td>
                <td>o	</td>
            </tr>
            <tr>
                <td>o	 </td>
                <td>o	</td>
            </tr>
            <tr>
                <td>o	</td>
                <td>o	</td>
            </tr>
        </table>
        <p>PAXLOVID</p>
        <p></p>
        <ul>
          <li></li>
          <li></li>
          <li></li>
          <li></li>
          <li></li>
          <li></li>
        </ul>
        <p> PAXLOVID </p>
        <p>PAXLOVID</p>
        <ul>
          <li> PAXLOVID  25C</li>
        </ul>
        <p>PAXLOVID</p>
        <p>PAXLOVID</p>
        <p>PAXLOVIDPAXLOVIDPAXLOVID</p>
        <p>PAXLOVID</p>
        <p>nirmatrelvir  ritonavir</p>
        <p>Nirmatrelvir colloidal silicon dioxide, croscarmellose sodium, lactose monohydrate, microcrystalline cellulose, and sodium stearyl fumaratehydroxy propyl methylcellulose, iron oxide red, polyethylene glycol, and titanium dioxide</p>
        <p>Ritonavir copovidone, sorbitan laurate, silica colloidal anhydrous, calcium hydrogen phosphate anhydrous and sodium stearyl fumaratehypromellose, titanium dioxide, macrogol, hydroxypropyl cellulose, talc, silica colloidal anhydrous and polysorbate 80</p>
        <p>: USPI 202305-1</p>
      </div>
          </text>
        </section>  
          <section>
            <title value="SPL UNCLASSIFIED SECTION"/>
            <code>
              <coding>
                <system value="2.16.840.1.113883.6.1"/>
                <code value="34066-1"/>
                <display value="OTHER"/>
              </coding>
            </code>
            <text>
              <status value="generated"/>
              <div xmlns="http://www.w3.org/1999/xhtml">
                <p></p>
                <p>: USPI 202305-2</p>
                <p>  </p>
                <p>Nirmatrelvir 150 mg Film-Coated Tablets()Pfizer Manufacturing Deutschland GmbH</p>
                <p>Betriebssttte Freiburg, Mooswaldallee 1, D-79090 Freiburg, Germany.</p>
                <p>Nirmatrelvir 150 mg Film-Coated Tablets()Pfizer Italia S.r.L</p>
                <p>Localita Marino Del Tronto, 63100, Ascoli Piceno, Italy.</p>
                <p>  </p>
                <p>Ritonavir 100 mg Film-Coated TabletsHetero Labs Ltd., Unit III</p>
                <p>22-110, Industrial Development Area, Jeedimetla, Hyderabad, Telangana, India, 500055.</p>
                <p>Ritonavir 100 mg Film-Coated Tablets ()Pfizer Manufacturing Deutschland GmbH</p>
                <p>Betriebssttte Freiburg,Mooswaldallee 1, D-79090 Freiburg, Germany.</p>
                <p>Ritonavir 100 mg Film-Coated Tablets ()Pfizer Italia S.r.L</p>
                <p>Localita Marino Del Tronto, 63100, Ascoli Piceno, Italy.</p>
                <p>  </p>
                <p>    :</p>
                <p>    :1004243</p>
              </div>
            </text>
          </section>
        </section>
        </section>
        </section> 
        
    
      </Composition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="RegulatedAuthorization/authorizationpaxlovid" />
    <resource>
      <RegulatedAuthorization>
        <id value="authorizationpaxlovid" />
        <meta>
          <profile
            value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/RegulatedAuthorization-uv-epi" />
        </meta>
        <identifier>
          <use value="official" />
          <system value="https://spor.ema.europa.eu/pmswi" />
          <value value="6ae5b5d9-7372-494c-874b-7dc67d386d2e" />
        </identifier>
        <subject>
          <reference value="MedicinalProductDefinition/cfaeff60-72ff-42e0-bf17-d56db0f2da16" />
        </subject>
        <type>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi" />
            <code value="220000000061" />
            <display value="Marketing Authorisation" />
          </coding>
        </type>
        <region>
          <coding>
            <system value="urn:iso:std:iso:3166" />
            <code value="TW" />
            <display value="Taiwan" />
          </coding>
        </region>
        <status>
          <coding>
            <system value="http://hl7.org/fhir/publication-status" />
            <code value="active" />
            <display value="Active" />
          </coding>
        </status>
        <statusDate value="2022-03-01T00:00:00Z" />
        <holder>
          <reference value="Organization/e7fec37a-af43-4b91-9ec3-e7b2c5cb869b" />
        </holder>
      </RegulatedAuthorization>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:e7fec37a-af43-4b91-9ec3-e7b2c5cb869b"/>
    <resource>
      <Organization>
        <id value="e7fec37a-af43-4b91-9ec3-e7b2c5cb869b"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://mcp.fda.gov.tw/"/>
          <value value="e7fec37a-af43-4b91-9ec3-e7b2c5cb869b"/>
        </identifier>
        <active value="true"/>
        <type>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="220000000034"/>
            <display value="Marketing authorisation holder"/>
          </coding>
        </type>
        <name value=""/>
        <contact>
          <address>
            <use value="work"/>
            <type value="physical"/>
            <text value="1004243"/>
            <line value="1004243"/>
            <city value=""/>
            <country value="TW"/>
          </address>
        </contact>
      </Organization>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:a773ccac-5988-4a1d-9723-17bd58eb7a36"/>
    <resource>
      <Organization>
        <id value="a773ccac-5988-4a1d-9723-17bd58eb7a36"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://mcp.fda.gov.tw/"/>
          <value value="a773ccac-5988-4a1d-9723-17bd58eb7a36"/>
        </identifier>
        <active value="true"/>
        <type>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="220000000033"/>
            <display value="Manufacturer"/>
          </coding>
        </type>
        <name value="Pfizer Manufacturing Deutschland GmbH"/>
        <contact>
          <address>
            <use value="work"/>
            <type value="physical"/>
            <text value="Mooswaldallee 1, Bruehl, Freiburg Im Breisgau, Baden-Wuerttemberg, 79108, Germany"/>
            <line value="Mooswaldallee 1, Bruehl, Freiburg Im Breisgau, Baden-Wuerttemberg"/>
            <city value="Freiburg Im Breisgau"/>
            <country value="DE"/>
          </address>
        </contact>
      </Organization>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:123f09dd-7fbd-415e-966a-cf2c8ae08cc8"/>
    <resource>
      <Organization>
        <id value="123f09dd-7fbd-415e-966a-cf2c8ae08cc8"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://mcp.fda.gov.tw/"/>
          <value value="123f09dd-7fbd-415e-966a-cf2c8ae08cc8"/>
        </identifier>
        <active value="true"/>
        <type>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="220000000033"/>
            <display value="Manufacturer"/>
          </coding>
        </type>
        <name value="Pfizer Italia S.r.L"/>
        <contact>
          <address>
            <use value="work"/>
            <type value="physical"/>
            <text value="Localita Marino Del Tronto, Ascoli Piceno, AP, 63100, Italy"/>
            <line value="Localita Marino Del Tronto"/>
            <city value="Ascoli Piceno"/>
            <country value="IT"/>
          </address>
        </contact>
      </Organization>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:98978892-7f39-4f51-a7e9-fa2bd11c171d"/>
    <resource>
      <Organization>
        <id value="98978892-7f39-4f51-a7e9-fa2bd11c171d"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Organization-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://mcp.fda.gov.tw/"/>
          <value value="98978892-7f39-4f51-a7e9-fa2bd11c171d"/>
        </identifier>
        <active value="true"/>
        <type>
          <coding>
            <system value="https://spor.ema.europa.eu/rmswi"/>
            <code value="220000000033"/>
            <display value="Manufacturer"/>
          </coding>
        </type>
        <name value="Hetero Labs Ltd., Unit III"/>
        <contact>
          <address>
            <use value="work"/>
            <type value="physical"/>
            <text value="22-110, Industrial Development Area, Jeedimetla, Hyderabad, Telangana, India, 500055."/>
            <line value="22-110, Industrial Development Area"/>
            <city value="Telangana"/>
            <country value="IN"/>
          </address>
        </contact>
      </Organization>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:cfaeff60-72ff-42e0-bf17-d56db0f2da16"/>
    <resource>
      <MedicinalProductDefinition>
        <id value="cfaeff60-72ff-42e0-bf17-d56db0f2da16"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/MedicinalProductDefinition-uv-epi"/>
        </meta>
        <identifier>
          <system value="https://mcp.fda.gov.tw/"/>
          <value value="cfaeff60-72ff-42e0-bf17-d56db0f2da16"/>
        </identifier>
        <type>
          <coding>
            <system value="http://hl7.org/fhir/medicinal-product-type"/>
            <code value="MedicinalProduct"/>
            <display value=""/>
          </coding>
        </type>
        <domain>
          <coding>
            <system value="http://hl7.org/fhir/medicinal-product-domain"/>
            <code value="Human"/>
            <display value=""/>
          </coding>
        </domain>
        <status>
          <coding>
            <system value="http://hl7.org/fhir/publication-status"/>
            <code value="active"/>
            <display value="Active"/>
          </coding>
        </status>
        <statusDate value="2024-01-31T00:00:00Z"/>
        <legalStatusOfSupply>
          <coding>
            <system value="http://hl7.org/fhir/legal-status-of-supply"/>
            <code value="100000072084"/>
            <display value=""/>
          </coding>
        </legalStatusOfSupply>
        <classification>
					<coding>
						<system value="http://hl7.org/fhir/ValueSet/medicinal-product-classification"/>
						<code value="J05AE30"/>
						<display value=" "/>
					</coding>
				</classification>
        <route>
					<coding>
						<system value="http://hl7.org/fhir/uv/emedicinal-product-info/ValueSet/routeOfAdministration"/>
						<code value="26643006"/>
						<display value=""/>
					</coding>
				</route>
        <name>
          <productName value="150/100"/>
          <usage>
            <country>
              <coding>
                <system value="http://hl7.org/fhir/ValueSet/country"/>
                <code value="TW"/>
                <display value="Taiwan"/>
              </coding>
            </country>
            <jurisdiction>
              <coding>
                <system value="http://hl7.org/fhir/ValueSet/jurisdiction"/>
                <code value="TW"/>
                <display value="Taiwan"/>
              </coding>
            </jurisdiction>
            <language>
              <coding>
                <system value="http://hl7.org/fhir/ValueSet/all-languages"/>
                <code value="zh"/>
                <display value="Chinese"/>
              </coding>
            </language>
          </usage>
        </name>
      </MedicinalProductDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:9597af0f-64da-44eb-a05a-b302e2e5eb1d"/>
    <resource>
      <PackagedProductDefinition>
        <id value="9597af0f-64da-44eb-a05a-b302e2e5eb1d"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/PackagedProductDefinition-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://mcp.fda.gov.tw/"/>
          <value value="594b9632-affb-4108-88ac-caad7541af00"/>
        </identifier>
        <name value="150/100  x 30 "/>
        <type>
          <coding>
            <system value="http://hl7.org/fhir/medicinal-product-type"/>
            <code value="MedicinalProduct"/>
            <display value=""/>
          </coding>
        </type>
        <packageFor>
          <reference value="urn:uuid:cfaeff60-72ff-42e0-bf17-d56db0f2da16"/>
        </packageFor>
        <status>
          <coding>
            <system value="http://hl7.org/fhir/publication-status"/>
            <code value="active"/>
            <display value="Active"/>
          </coding>
        </status>
        <statusDate value="2024-01-31T00:00:00Z"/>
        <containedItemQuantity>
          <value value="150"/>
          <unit value=""/>
        </containedItemQuantity>
        <packaging>
          <identifier>
            <system value="https://mcp.fda.gov.tw/"/>
            <value value="aeae17de-9dd9-4f67-86ad-2c078f60a445"/>
          </identifier>
          <type>
            <coding>
              <system value="http://hl7.org/fhir/medicinal-product-package-type"/>
              <code value="100000073496"/>
              <display value=""/>
            </coding>
          </type>
          <quantity value="30"/>
          <material>
            <coding>
              <system value="http://hl7.org/fhir/package-material"/>
              <code value="200000003210"/>
              <display value="Orientated PolyAmide"/>
            </coding>
            <coding>
              <system value="http://hl7.org/fhir/package-material"/>
              <code value="200000003200"/>
              <display value="Aluminium"/>
            </coding>
            <coding>
              <system value="http://hl7.org/fhir/package-material"/>
              <code value="200000003222"/>
              <display value="PolyVinyl Chloride"/>
            </coding>
          </material>
        </packaging>
      </PackagedProductDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:4e0f663a-3b69-41cf-a3c0-416206d0deee"/>
    <resource>
      <AdministrableProductDefinition>
        <id value="4e0f663a-3b69-41cf-a3c0-416206d0deee"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/AdministrableProductDefinition-uv-epi"/>
        </meta>
        <identifier>
          <system value="https://www.who-umc.org/phpid"/>
          <value value="236b14ee-38bc-41ec-801a-b2c229a75e64"/>
        </identifier>
        <status value="active"/>
        <formOf>
          <reference value="urn:uuid:cfaeff60-72ff-42e0-bf17-d56db0f2da16"/>
        </formOf>
        <administrableDoseForm>
          <coding>
            <system value="http://hl7.org/fhir/administrable-dose-form"/>
            <code value="100000073665"/>
            <display value=""/>
          </coding>
        </administrableDoseForm>
        <unitOfPresentation>
          <coding>
            <system value="http://hl7.org/fhir/unit-of-presentation"/>
            <code value="200000002152"/>
            <display value=""/>
          </coding>
        </unitOfPresentation>
        <producedFrom>
          <reference value="urn:uuid:3214f286-b8ec-4ef5-bc8d-0aec39d97468"/>
        </producedFrom>
        <routeOfAdministration>
          <code>
            <coding>
              <system value="http://snomed.info/sct"/>
              <code value="26643006"/>
              <display value=""/>
            </coding>
          </code>
        </routeOfAdministration>
      </AdministrableProductDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:391fe0c6-50cc-45df-86ef-e0ec7cf6ab7f"/>
    <resource>
      <AdministrableProductDefinition>
        <id value="391fe0c6-50cc-45df-86ef-e0ec7cf6ab7f"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/AdministrableProductDefinition-uv-epi"/>
        </meta>
        <identifier>
          <system value="https://www.who-umc.org/phpid"/>
          <value value="10f671c1-cec0-4d00-9dfe-316b76804b6c"/>
        </identifier>
        <status value="active"/>
        <formOf>
          <reference value="urn:uuid:cfaeff60-72ff-42e0-bf17-d56db0f2da16"/>
        </formOf>
        <administrableDoseForm>
          <coding>
            <system value="http://hl7.org/fhir/administrable-dose-form"/>
            <code value="100000073665"/>
            <display value=""/>
          </coding>
        </administrableDoseForm>
        <unitOfPresentation>
          <coding>
            <system value="http://hl7.org/fhir/unit-of-presentation"/>
            <code value="200000002152"/>
            <display value=""/>
          </coding>
        </unitOfPresentation>
        <producedFrom>
          <reference value="urn:uuid:c984b49f-f53d-468f-af0f-6f12ecc678e9"/>
        </producedFrom>
        <routeOfAdministration>
          <code>
            <coding>
              <system value="http://snomed.info/sct"/>
              <code value="26643006"/>
              <display value=""/>
            </coding>
          </code>
        </routeOfAdministration>
      </AdministrableProductDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:3214f286-b8ec-4ef5-bc8d-0aec39d97468"/>
    <resource>
      <ManufacturedItemDefinition>
        <id value="3214f286-b8ec-4ef5-bc8d-0aec39d97468"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://mcp.fda.gov.tw/"/>
          <value value="473f236d-9d51-47e7-9e27-576be2c266a1"/>
        </identifier>
        <name value="Nirmatrelvir 150"/>
        <status value="active"/>
        <manufacturedDoseForm>
          <coding>
            <system value="http://hl7.org/fhir/manufactured-dose-form"/>
            <code value="100000073665"/>
            <display value=""/>
          </coding>
        </manufacturedDoseForm>
        <unitOfPresentation>
          <coding>
            <system value="http://hl7.org/fhir/unit-of-presentation"/>
            <code value="200000002152"/>
            <display value=""/>
          </coding>
        </unitOfPresentation>
        <manufacturer>
          <reference value="urn:uuid:a773ccac-5988-4a1d-9723-17bd58eb7a36"/>
        </manufacturer> 
        <manufacturer>
          <reference value="urn:uuid:123f09dd-7fbd-415e-966a-cf2c8ae08cc8"/>
        </manufacturer>
      </ManufacturedItemDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:c984b49f-f53d-468f-af0f-6f12ecc678e9"/>
    <resource>
      <ManufacturedItemDefinition>
        <id value="c984b49f-f53d-468f-af0f-6f12ecc678e9"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/ManufacturedItemDefinition-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://mcp.fda.gov.tw/"/>
          <value value="3ab80f4d-3932-47cd-89c6-c480006fd7cc"/>
        </identifier>
        <name value="Ritonavir 100"/>
        <status value="active"/>
        <manufacturedDoseForm>
          <coding>
            <system value="http://hl7.org/fhir/manufactured-dose-form"/>
            <code value="100000073665"/>
            <display value=""/>
          </coding>
        </manufacturedDoseForm>
        <unitOfPresentation>
          <coding>
            <system value="http://hl7.org/fhir/unit-of-presentation"/>
            <code value="200000002152"/>
            <display value=""/>
          </coding>
        </unitOfPresentation>
        <manufacturer>
          <reference value="urn:uuid:98978892-7f39-4f51-a7e9-fa2bd11c171d"/>
        </manufacturer>
        <manufacturer>
          <reference value="urn:uuid:a773ccac-5988-4a1d-9723-17bd58eb7a36"/>
        </manufacturer>
        <manufacturer>
          <reference value="urn:uuid:123f09dd-7fbd-415e-966a-cf2c8ae08cc8"/>
        </manufacturer>
      </ManufacturedItemDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:745c01bc-936e-45ca-9880-57e97608f43e"/>
    <resource>
      <Ingredient>
        <id value="745c01bc-936e-45ca-9880-57e97608f43e"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="7R9A5P7H32"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="urn:uuid:3214f286-b8ec-4ef5-bc8d-0aec39d97468"/>
        </for>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/ingredient-role"/>
            <code value="100000072072"/>
            <display value="Active"/>
          </coding>
        </role>
        <manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
                <code value="7R9A5P7H32"/>
                <display value="Nirmatrelvir"/>
              </coding>
            </concept>
          </code>
          <strength>
            <presentationQuantity>
              <value value="150"/>
              <unit value=""/>
            </presentationQuantity>
            <basis>
              <coding>
                <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
                <code value="ACTI"/>
              </coding>
              <text value="active ingredient"/>
            </basis>
          </strength>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:792d123b-b476-4846-8c37-257cb02015f8"/>
    <resource>
      <Ingredient>
        <id value="792d123b-b476-4846-8c37-257cb02015f8"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="O3J8G9O825"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="urn:uuid:c984b49f-f53d-468f-af0f-6f12ecc678e9"/>
        </for>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/ingredient-role"/>
            <code value="100000072072"/>
            <display value="Active"/>
          </coding>
        </role>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
                <code value="O3J8G9O825"/>
                <display value="Ritonavir"/>
              </coding>
            </concept>
          </code>
          <strength>
            <presentationQuantity>
              <value value="100"/>
              <unit value=""/>
            </presentationQuantity>
            <basis>
              <coding>
                <system value="http://terminology.hl7.org/CodeSystem/v3-RoleClass"/>
                <code value="ACTI"/>
              </coding>
              <text value="active ingredient"/>
            </basis>
          </strength>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:09c13040-8fd5-4818-972d-f01d4ee169b6"/>
    <resource>
      <Ingredient>
        <id value="09c13040-8fd5-4818-972d-f01d4ee169b6"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="ETJ7Z6XBU4"/>
        </identifier>
        <status value="active"/>
        <for>
        <reference value="urn:uuid:3214f286-b8ec-4ef5-bc8d-0aec39d97468"/>
        </for>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/ingredient-role"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
                <code value="ETJ7Z6XBU4"/>
                <display value="Silicon dioxide, colloidal"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:80c1871d-955b-452c-b486-1c008a49f94e"/>
    <resource>
      <Ingredient>
        <id value="80c1871d-955b-452c-b486-1c008a49f94e"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="M28OL1HH48"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="urn:uuid:3214f286-b8ec-4ef5-bc8d-0aec39d97468"/>
        </for>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/ingredient-role"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
                <code value="M28OL1HH48"/>
                <display value="Croscarmellose sodium"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:87772b11-f10f-4000-bcc5-6331da1317d9"/>
    <resource>
      <Ingredient>
        <id value="87772b11-f10f-4000-bcc5-6331da1317d9"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="EWQ57Q8I5X"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="urn:uuid:3214f286-b8ec-4ef5-bc8d-0aec39d97468"/>
        </for>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/ingredient-role"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
                <code value="EWQ57Q8I5X"/>
                <display value="Lactose monohydrate"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:a70e0d77-7023-4f0a-8543-29b88b79e3fb"/>
    <resource>
      <Ingredient>
        <id value="a70e0d77-7023-4f0a-8543-29b88b79e3fb"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="OP1R32D61U"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="urn:uuid:3214f286-b8ec-4ef5-bc8d-0aec39d97468"/>
        </for>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/ingredient-role"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
                <code value="OP1R32D61U"/>
                <display value="Microcrystalline cellulose"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:d0ec45e8-1b9a-4ffb-af8c-a3cbf40b7cbd"/>
    <resource>
      <Ingredient>
        <id value="d0ec45e8-1b9a-4ffb-af8c-a3cbf40b7cbd"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="7CV7WJK4UI"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="urn:uuid:3214f286-b8ec-4ef5-bc8d-0aec39d97468"/>
        </for>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/ingredient-role"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
                <code value="7CV7WJK4UI"/>
                <display value="Sodium stearyl fumarate"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:5a2530c8-4599-4fb3-b0e2-df8b29b03bba"/>
    <resource>
      <Ingredient>
        <id value="5a2530c8-4599-4fb3-b0e2-df8b29b03bba"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="3NXW29V3WO"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="urn:uuid:3214f286-b8ec-4ef5-bc8d-0aec39d97468"/>
        </for>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/ingredient-role"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
                <code value="3NXW29V3WO"/>
                <display value="Hydroxypropyl methylcellulose"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:b717362f-5bdc-4618-8e40-81171e75cd2d"/>
    <resource>
      <Ingredient>
        <id value="b717362f-5bdc-4618-8e40-81171e75cd2d"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="1K09F3G675"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="urn:uuid:3214f286-b8ec-4ef5-bc8d-0aec39d97468"/>
        </for>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/ingredient-role"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
                <code value="1K09F3G675"/>
                <display value="Iron oxide red"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:9d9a4607-9728-40f5-9f0f-3f190416a527"/>
    <resource>
      <Ingredient>
        <id value="9d9a4607-9728-40f5-9f0f-3f190416a527"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="3WJQ0SDW1A"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="urn:uuid:3214f286-b8ec-4ef5-bc8d-0aec39d97468"/>
        </for>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/ingredient-role"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
                <code value="3WJQ0SDW1A"/>
                <display value="Polyethylene glycol"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:3fc6c9e0-da0f-44d6-93b7-16590597f7b6"/>
    <resource>
      <Ingredient>
        <id value="3fc6c9e0-da0f-44d6-93b7-16590597f7b6"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="15FIX9V2JP"/>
        </identifier>
        <status value="active"/>
        <for>
        <reference value="urn:uuid:3214f286-b8ec-4ef5-bc8d-0aec39d97468"/>
        </for>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/ingredient-role"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
                <code value="15FIX9V2JP"/>
                <display value="Titanium Dioxide"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:dacf1690-984b-4b75-b39c-9ab42f0ed662"/>
    <resource>
      <Ingredient>
        <id value="dacf1690-984b-4b75-b39c-9ab42f0ed662"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="D9C330MD8B"/>
        </identifier>
        <status value="active"/>
        <for>
        <reference value="urn:uuid:c984b49f-f53d-468f-af0f-6f12ecc678e9"/>
        </for>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/ingredient-role"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
                <code value="D9C330MD8B"/>
                <display value="Copovidone"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:3fc6c9e0-da0f-44d6-93b7-16590597f7b6"/>
    <resource>
      <Ingredient>
        <id value="3fc6c9e0-da0f-44d6-93b7-16590597f7b6"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="6W9PS8B71J"/>
        </identifier>
        <status value="active"/>
        <for>
        <reference value="urn:uuid:c984b49f-f53d-468f-af0f-6f12ecc678e9"/>
        </for>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/ingredient-role"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
                <code value="6W9PS8B71J"/>
                <display value="Sorbitan laurate"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:73445cfe-fcfc-4e6a-9c4a-8ef53cfc5095"/>
    <resource>
      <Ingredient>
        <id value="73445cfe-fcfc-4e6a-9c4a-8ef53cfc5095"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="ETJ7Z6XBU4"/>
        </identifier>
        <status value="active"/>
        <for>
        <reference value="urn:uuid:c984b49f-f53d-468f-af0f-6f12ecc678e9"/>
        </for>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/ingredient-role"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
                <code value="ETJ7Z6XBU4"/>
                <display value="Silica colloidal anhydrous"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:96ab37c6-19e1-42a1-ba44-b547e736cbad"/>
    <resource>
      <Ingredient>
        <id value="96ab37c6-19e1-42a1-ba44-b547e736cbad"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="L11K75P92J"/>
        </identifier>
        <status value="active"/>
        <for>
        <reference value="urn:uuid:c984b49f-f53d-468f-af0f-6f12ecc678e9"/>
        </for>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/ingredient-role"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
                <code value="L11K75P92J"/>
                <display value="Calcium hydrogen phosphate anhydrous"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:581adab7-846f-4555-93ba-1d5be1bf740d"/>
    <resource>
      <Ingredient>
        <id value="581adab7-846f-4555-93ba-1d5be1bf740d"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="7CV7WJK4UI"/>
        </identifier>
        <status value="active"/>
        <for>
          <reference value="urn:uuid:c984b49f-f53d-468f-af0f-6f12ecc678e9"/>
        </for>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/ingredient-role"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
                <code value="7CV7WJK4UI"/>
                <display value="Sodium stearyl fumarate"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:2aeb8dda-b7f6-4156-9328-7cbcbd6d6328"/>
    <resource>
      <Ingredient>
        <id value="2aeb8dda-b7f6-4156-9328-7cbcbd6d6328"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="3NXW29V3WO"/>
        </identifier>
        <status value="active"/>
        <for>
        <reference value="urn:uuid:c984b49f-f53d-468f-af0f-6f12ecc678e9"/>
        </for>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/ingredient-role"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
                <code value="3NXW29V3WO"/>
                <display value="Hypromellose"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:adb44c23-3430-4563-80dc-7c09163300f2"/>
    <resource>
      <Ingredient>
        <id value="adb44c23-3430-4563-80dc-7c09163300f2"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="15FIX9V2JP"/>
        </identifier>
        <status value="active"/>
        <for>
        <reference value="urn:uuid:c984b49f-f53d-468f-af0f-6f12ecc678e9"/>
        </for>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/ingredient-role"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
                <code value="15FIX9V2JP"/>
                <display value="Titanium Dioxide"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:e7af6f11-5f61-47c6-ba60-6130776803b9"/>
    <resource>
      <Ingredient>
        <id value="e7af6f11-5f61-47c6-ba60-6130776803b9"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="3WJQ0SDW1A"/>
        </identifier>
        <status value="active"/>
        <for>
        <reference value="urn:uuid:c984b49f-f53d-468f-af0f-6f12ecc678e9"/>
        </for>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/ingredient-role"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
                <code value="3WJQ0SDW1A"/>
                <display value="Macrogol"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:3e1df278-c76a-4c00-991a-80e399a6ea20"/>
    <resource>
      <Ingredient>
        <id value="3e1df278-c76a-4c00-991a-80e399a6ea20"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="9XZ8H6N6OH"/>
        </identifier>
        <status value="active"/>
        <for>
        <reference value="urn:uuid:c984b49f-f53d-468f-af0f-6f12ecc678e9"/>
        </for>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/ingredient-role"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
                <code value="9XZ8H6N6OH"/>
                <display value="Hydroxypropyl cellulose"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:cc341cf7-e010-4d71-bda5-06cc7f09974f"/>
    <resource>
      <Ingredient>
        <id value="cc341cf7-e010-4d71-bda5-06cc7f09974f"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="7SEV7J4R1U"/>
        </identifier>
        <status value="active"/>
        <for>
        <reference value="urn:uuid:c984b49f-f53d-468f-af0f-6f12ecc678e9"/>
        </for>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/ingredient-role"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
                <code value="7SEV7J4R1U"/>
                <display value="Talc"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:92427491-7091-4952-9f73-e2d77ee3aaa2"/>
    <resource>
      <Ingredient>
        <id value="92427491-7091-4952-9f73-e2d77ee3aaa2"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="ETJ7Z6XBU4"/>
        </identifier>
        <status value="active"/>
        <for>
        <reference value="urn:uuid:c984b49f-f53d-468f-af0f-6f12ecc678e9"/>
        </for>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/ingredient-role"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
                <code value="ETJ7Z6XBU4"/>
                <display value="Silica colloidal anhydrous"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:cc341cf7-e010-4d71-bda5-06cc7f09974f"/>
    <resource>
      <Ingredient>
        <id value="cc341cf7-e010-4d71-bda5-06cc7f09974f"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/Ingredient-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
          <value value="6OZP39ZG8H"/>
        </identifier>
        <status value="active"/>
        <for>
        <reference value="urn:uuid:c984b49f-f53d-468f-af0f-6f12ecc678e9"/>
        </for>
        <role>
          <coding>
            <system value="http://hl7.org/fhir/ingredient-role"/>
            <code value="100000072082"/>
            <display value="Excipient"/>
          </coding>
        </role>
        <manufacturer>
        </manufacturer>
        <substance>
          <code>
            <concept>
              <coding>
                <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
                <code value="6OZP39ZG8H"/>
                <display value="polysorbate 80"/>
              </coding>
            </concept>
          </code>
        </substance>
      </Ingredient>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:7f19fe21-8a9b-4ee9-945f-872be96703ff"/>
    <resource>
      <SubstanceDefinition>
        <id value="7f19fe21-8a9b-4ee9-945f-872be96703ff"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/SubstanceDefinition-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
          <value value="7R9A5P7H32"/>
        </identifier>
        <version value="1"/>
        <status>
          <coding>
            <system value="http://hl7.org/fhir/publication-status"/>
            <code value="active"/>
          </coding>
        </status>
        <description value="Pink, oval, debossing of 'PFE' on one side and '3CL' on the other side."/>
        <molecularWeight>
          <type>
            <text value="exact"/>
          </type>
          <amount>
            <value value="499.53"/>
          </amount>
        </molecularWeight>
        <structure>
          <molecularFormula value="C23H32F3N5O4"/>
        </structure>
        <name>
          <name value="Nirmatrelvir"/>
          <type>
            <coding>
              <system value="http://hl7.org/fhir/substance-name-type"/>
              <code value="Scientific"/>
            </coding>
            <text value="Scientific"/>
          </type>
        </name>
      </SubstanceDefinition>
    </resource>
  </entry>
  <entry>
    <fullUrl value="urn:uuid:b0846e21-502f-4e34-adbe-f73f6962ac8f"/>
    <resource>
      <SubstanceDefinition>
        <id value="b0846e21-502f-4e34-adbe-f73f6962ac8f"/>
        <meta>
          <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/SubstanceDefinition-uv-epi"/>
        </meta>
        <identifier>
          <use value="official"/>
          <system value="https://gsrs.ncats.nih.gov/ginas/app/beta"/>
          <value value="O3J8G9O825"/>
        </identifier>
        <version value="1"/>
        <status>
          <coding>
            <system value="http://hl7.org/fhir/publication-status"/>
            <code value="active"/>
          </coding>
        </status>
        <description value="White to off white, capsule shaped film coated tablets, debossed with 'H' on one side and 'R9' on other side"/>
        <molecularWeight>
          <type>
            <text value="exact"/>
          </type>
          <amount>
            <value value="720.95"/>
          </amount>
        </molecularWeight>
        <structure>
          <molecularFormula value="C37H48N6O5S2"/>
        </structure>
        <name>
          <name value="Ritonavir"/>
          <type>
            <coding>
              <system value="http://hl7.org/fhir/substance-name-type"/>
              <code value="Scientific"/>
            </coding>
            <text value="Scientific"/>
          </type>
        </name>
      </SubstanceDefinition>
    </resource>
  </entry>
</Bundle>
